The Market Reports

Index

1 GP Vaccination Market Overview
1.1 Product Overview and Scope of GP Vaccination
1.2 GP Vaccination Segment by Type
1.2.1 Global GP Vaccination Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 GP Vaccination Segment by Application
1.3.1 Global GP Vaccination Sales Comparison by Application: (2022-2028)
1.3.2 Adults
1.3.3 Children
1.4 Global GP Vaccination Market Size Estimates and Forecasts
1.4.1 Global GP Vaccination Revenue 2017-2028
1.4.2 Global GP Vaccination Sales 2017-2028
1.4.3 GP Vaccination Market Size by Region: 2017 Versus 2021 Versus 2028
2 GP Vaccination Market Competition by Manufacturers
2.1 Global GP Vaccination Sales Market Share by Manufacturers (2017-2022)
2.2 Global GP Vaccination Revenue Market Share by Manufacturers (2017-2022)
2.3 Global GP Vaccination Average Price by Manufacturers (2017-2022)
2.4 Manufacturers GP Vaccination Manufacturing Sites, Area Served, Product Type
2.5 GP Vaccination Market Competitive Situation and Trends
2.5.1 GP Vaccination Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest GP Vaccination Players Market Share by Revenue
2.5.3 Global GP Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 GP Vaccination Retrospective Market Scenario by Region
3.1 Global GP Vaccination Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global GP Vaccination Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America GP Vaccination Market Facts & Figures by Country
3.3.1 North America GP Vaccination Sales by Country
3.3.2 North America GP Vaccination Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe GP Vaccination Market Facts & Figures by Country
3.4.1 Europe GP Vaccination Sales by Country
3.4.2 Europe GP Vaccination Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific GP Vaccination Market Facts & Figures by Region
3.5.1 Asia Pacific GP Vaccination Sales by Region
3.5.2 Asia Pacific GP Vaccination Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America GP Vaccination Market Facts & Figures by Country
3.6.1 Latin America GP Vaccination Sales by Country
3.6.2 Latin America GP Vaccination Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa GP Vaccination Market Facts & Figures by Country
3.7.1 Middle East and Africa GP Vaccination Sales by Country
3.7.2 Middle East and Africa GP Vaccination Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global GP Vaccination Historic Market Analysis by Type
4.1 Global GP Vaccination Sales Market Share by Type (2017-2022)
4.2 Global GP Vaccination Revenue Market Share by Type (2017-2022)
4.3 Global GP Vaccination Price by Type (2017-2022)
5 Global GP Vaccination Historic Market Analysis by Application
5.1 Global GP Vaccination Sales Market Share by Application (2017-2022)
5.2 Global GP Vaccination Revenue Market Share by Application (2017-2022)
5.3 Global GP Vaccination Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Moderna GP Vaccination Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 CanSino Biologicals
6.2.1 CanSino Biologicals Corporation Information
6.2.2 CanSino Biologicals Description and Business Overview
6.2.3 CanSino Biologicals GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.2.4 CanSino Biologicals GP Vaccination Product Portfolio
6.2.5 CanSino Biologicals Recent Developments/Updates
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Corporation Information
6.3.2 Inovio Pharmaceuticals Description and Business Overview
6.3.3 Inovio Pharmaceuticals GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Inovio Pharmaceuticals GP Vaccination Product Portfolio
6.3.5 Inovio Pharmaceuticals Recent Developments/Updates
6.4 Shenzhen Geno-Immune Medical Institute
6.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
6.4.2 Shenzhen Geno-Immune Medical Institute Description and Business Overview
6.4.3 Shenzhen Geno-Immune Medical Institute GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Shenzhen Geno-Immune Medical Institute GP Vaccination Product Portfolio
6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
6.5 GlaxoSmithKine
6.5.1 GlaxoSmithKine Corporation Information
6.5.2 GlaxoSmithKine Description and Business Overview
6.5.3 GlaxoSmithKine GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.5.4 GlaxoSmithKine GP Vaccination Product Portfolio
6.5.5 GlaxoSmithKine Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Pfizer GP Vaccination Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson＆Johnson
6.6.1 Johnson＆Johnson Corporation Information
6.6.2 Johnson＆Johnson Description and Business Overview
6.6.3 Johnson＆Johnson GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Johnson＆Johnson GP Vaccination Product Portfolio
6.7.5 Johnson＆Johnson Recent Developments/Updates
6.8 Heat Biologics
6.8.1 Heat Biologics Corporation Information
6.8.2 Heat Biologics Description and Business Overview
6.8.3 Heat Biologics GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Heat Biologics GP Vaccination Product Portfolio
6.8.5 Heat Biologics Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sanofi GP Vaccination Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Takis Biotech
6.10.1 Takis Biotech Corporation Information
6.10.2 Takis Biotech Description and Business Overview
6.10.3 Takis Biotech GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Takis Biotech GP Vaccination Product Portfolio
6.10.5 Takis Biotech Recent Developments/Updates
6.11 Zydus Cadila
6.11.1 Zydus Cadila Corporation Information
6.11.2 Zydus Cadila GP Vaccination Description and Business Overview
6.11.3 Zydus Cadila GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Zydus Cadila GP Vaccination Product Portfolio
6.11.5 Zydus Cadila Recent Developments/Updates
6.12 Codagenix
6.12.1 Codagenix Corporation Information
6.12.2 Codagenix GP Vaccination Description and Business Overview
6.12.3 Codagenix GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Codagenix GP Vaccination Product Portfolio
6.12.5 Codagenix Recent Developments/Updates
6.13 GeoVax
6.13.1 GeoVax Corporation Information
6.13.2 GeoVax GP Vaccination Description and Business Overview
6.13.3 GeoVax GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.13.4 GeoVax GP Vaccination Product Portfolio
6.13.5 GeoVax Recent Developments/Updates
6.14 Bravovax
6.14.1 Bravovax Corporation Information
6.14.2 Bravovax GP Vaccination Description and Business Overview
6.14.3 Bravovax GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Bravovax GP Vaccination Product Portfolio
6.14.5 Bravovax Recent Developments/Updates
6.15 Altimmune
6.15.1 Altimmune Corporation Information
6.15.2 Altimmune GP Vaccination Description and Business Overview
6.15.3 Altimmune GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Altimmune GP Vaccination Product Portfolio
6.15.5 Altimmune Recent Developments/Updates
6.16 Vaxart
6.16.1 Vaxart Corporation Information
6.16.2 Vaxart GP Vaccination Description and Business Overview
6.16.3 Vaxart GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Vaxart GP Vaccination Product Portfolio
6.16.5 Vaxart Recent Developments/Updates
6.17 Clover Biopharmaceuticals
6.17.1 Clover Biopharmaceuticals Corporation Information
6.17.2 Clover Biopharmaceuticals GP Vaccination Description and Business Overview
6.17.3 Clover Biopharmaceuticals GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Clover Biopharmaceuticals GP Vaccination Product Portfolio
6.17.5 Clover Biopharmaceuticals Recent Developments/Updates
6.18 ImmunoPrecise
6.18.1 ImmunoPrecise Corporation Information
6.18.2 ImmunoPrecise GP Vaccination Description and Business Overview
6.18.3 ImmunoPrecise GP Vaccination Sales, Revenue and Gross Margin (2017-2022)
6.18.4 ImmunoPrecise GP Vaccination Product Portfolio
6.18.5 ImmunoPrecise Recent Developments/Updates
7 GP Vaccination Manufacturing Cost Analysis
7.1 GP Vaccination Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of GP Vaccination
7.4 GP Vaccination Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 GP Vaccination Distributors List
8.3 GP Vaccination Customers
9 GP Vaccination Market Dynamics
9.1 GP Vaccination Industry Trends
9.2 GP Vaccination Market Drivers
9.3 GP Vaccination Market Challenges
9.4 GP Vaccination Market Restraints
10 Global Market Forecast
10.1 GP Vaccination Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of GP Vaccination by Type (2023-2028)
10.1.2 Global Forecasted Revenue of GP Vaccination by Type (2023-2028)
10.2 GP Vaccination Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of GP Vaccination by Application (2023-2028)
10.2.2 Global Forecasted Revenue of GP Vaccination by Application (2023-2028)
10.3 GP Vaccination Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of GP Vaccination by Region (2023-2028)
10.3.2 Global Forecasted Revenue of GP Vaccination by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global GP Vaccination Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global GP Vaccination Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global GP Vaccination Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global GP Vaccination Market Competitive Situation by Manufacturers in 2021
Table 5. Global GP Vaccination Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global GP Vaccination Sales Market Share by Manufacturers (2017-2022)
Table 7. Global GP Vaccination Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global GP Vaccination Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market GP Vaccination Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers GP Vaccination Manufacturing Sites and Area Served
Table 11. Manufacturers GP Vaccination Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global GP Vaccination by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GP Vaccination as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global GP Vaccination Sales by Region (2017-2022) & (K Units)
Table 16. Global GP Vaccination Sales Market Share by Region (2017-2022)
Table 17. Global GP Vaccination Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global GP Vaccination Revenue Market Share by Region (2017-2022)
Table 19. North America GP Vaccination Sales by Country (2017-2022) & (K Units)
Table 20. North America GP Vaccination Sales Market Share by Country (2017-2022)
Table 21. North America GP Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America GP Vaccination Revenue Market Share by Country (2017-2022)
Table 23. Europe GP Vaccination Sales by Country (2017-2022) & (K Units)
Table 24. Europe GP Vaccination Sales Market Share by Country (2017-2022)
Table 25. Europe GP Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe GP Vaccination Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific GP Vaccination Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific GP Vaccination Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific GP Vaccination Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific GP Vaccination Revenue Market Share by Region (2017-2022)
Table 31. Latin America GP Vaccination Sales by Country (2017-2022) & (K Units)
Table 32. Latin America GP Vaccination Sales Market Share by Country (2017-2022)
Table 33. Latin America GP Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America GP Vaccination Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa GP Vaccination Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa GP Vaccination Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa GP Vaccination Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa GP Vaccination Revenue Market Share by Country (2017-2022)
Table 39. Global GP Vaccination Sales by Type (2017-2022) & (K Units)
Table 40. Global GP Vaccination Sales Market Share by Type (2017-2022)
Table 41. Global GP Vaccination Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global GP Vaccination Revenue Share by Type (2017-2022)
Table 43. Global GP Vaccination Price by Type (2017-2022) & (US$/Unit)
Table 44. Global GP Vaccination Sales (K Units) by Application (2017-2022)
Table 45. Global GP Vaccination Sales Market Share by Application (2017-2022)
Table 46. Global GP Vaccination Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global GP Vaccination Revenue Share by Application (2017-2022)
Table 48. Global GP Vaccination Price by Application (2017-2022) & (US$/Unit)
Table 49. Moderna Corporation Information
Table 50. Moderna Description and Business Overview
Table 51. Moderna GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Moderna GP Vaccination Product
Table 53. Moderna Recent Developments/Updates
Table 54. CanSino Biologicals Corporation Information
Table 55. CanSino Biologicals Description and Business Overview
Table 56. CanSino Biologicals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. CanSino Biologicals GP Vaccination Product
Table 58. CanSino Biologicals Recent Developments/Updates
Table 59. Inovio Pharmaceuticals Corporation Information
Table 60. Inovio Pharmaceuticals Description and Business Overview
Table 61. Inovio Pharmaceuticals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Inovio Pharmaceuticals GP Vaccination Product
Table 63. Inovio Pharmaceuticals Recent Developments/Updates
Table 64. Shenzhen Geno-Immune Medical Institute Corporation Information
Table 65. Shenzhen Geno-Immune Medical Institute Description and Business Overview
Table 66. Shenzhen Geno-Immune Medical Institute GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Shenzhen Geno-Immune Medical Institute GP Vaccination Product
Table 68. Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
Table 69. GlaxoSmithKine Corporation Information
Table 70. GlaxoSmithKine Description and Business Overview
Table 71. GlaxoSmithKine GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. GlaxoSmithKine GP Vaccination Product
Table 73. GlaxoSmithKine Recent Developments/Updates
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Business Overview
Table 76. Pfizer GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Pfizer GP Vaccination Product
Table 78. Pfizer Recent Developments/Updates
Table 79. Johnson＆Johnson Corporation Information
Table 80. Johnson＆Johnson Description and Business Overview
Table 81. Johnson＆Johnson GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Johnson＆Johnson GP Vaccination Product
Table 83. Johnson＆Johnson Recent Developments/Updates
Table 84. Heat Biologics Corporation Information
Table 85. Heat Biologics Description and Business Overview
Table 86. Heat Biologics GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Heat Biologics GP Vaccination Product
Table 88. Heat Biologics Recent Developments/Updates
Table 89. Sanofi Corporation Information
Table 90. Sanofi Description and Business Overview
Table 91. Sanofi GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Sanofi GP Vaccination Product
Table 93. Sanofi Recent Developments/Updates
Table 94. Takis Biotech Corporation Information
Table 95. Takis Biotech Description and Business Overview
Table 96. Takis Biotech GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Takis Biotech GP Vaccination Product
Table 98. Takis Biotech Recent Developments/Updates
Table 99. Zydus Cadila Corporation Information
Table 100. Zydus Cadila Description and Business Overview
Table 101. Zydus Cadila GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Zydus Cadila GP Vaccination Product
Table 103. Zydus Cadila Recent Developments/Updates
Table 104. Codagenix Corporation Information
Table 105. Codagenix Description and Business Overview
Table 106. Codagenix GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Codagenix GP Vaccination Product
Table 108. Codagenix Recent Developments/Updates
Table 109. GeoVax Corporation Information
Table 110. GeoVax Description and Business Overview
Table 111. GeoVax GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. GeoVax GP Vaccination Product
Table 113. GeoVax Recent Developments/Updates
Table 114. Bravovax Corporation Information
Table 115. Bravovax Description and Business Overview
Table 116. Bravovax GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Bravovax GP Vaccination Product
Table 118. Bravovax Recent Developments/Updates
Table 119. Altimmune Corporation Information
Table 120. Altimmune Description and Business Overview
Table 121. Altimmune GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Altimmune GP Vaccination Product
Table 123. Altimmune Recent Developments/Updates
Table 124. Vaxart Corporation Information
Table 125. Vaxart Description and Business Overview
Table 126. Vaxart GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Vaxart GP Vaccination Product
Table 128. Vaxart Recent Developments/Updates
Table 129. Clover Biopharmaceuticals Corporation Information
Table 130. Clover Biopharmaceuticals Description and Business Overview
Table 131. Clover Biopharmaceuticals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Clover Biopharmaceuticals GP Vaccination Product
Table 133. Clover Biopharmaceuticals Recent Developments/Updates
Table 134. ImmunoPrecise Corporation Information
Table 135. ImmunoPrecise Description and Business Overview
Table 136. ImmunoPrecise GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. ImmunoPrecise GP Vaccination Product
Table 138. ImmunoPrecise Recent Developments/Updates
Table 139. Production Base and Market Concentration Rate of Raw Material
Table 140. Key Suppliers of Raw Materials
Table 141. GP Vaccination Distributors List
Table 142. GP Vaccination Customers List
Table 143. GP Vaccination Market Trends
Table 144. GP Vaccination Market Drivers
Table 145. GP Vaccination Market Challenges
Table 146. GP Vaccination Market Restraints
Table 147. Global GP Vaccination Sales Forecast by Type (2023-2028) & (K Units)
Table 148. Global GP Vaccination Sales Market Share Forecast by Type (2023-2028)
Table 149. Global GP Vaccination Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 150. Global GP Vaccination Revenue Market Share Forecast by Type (2023-2028)
Table 151. Global GP Vaccination Sales Forecast by Application (2023-2028) & (K Units)
Table 152. Global GP Vaccination Sales Market Share Forecast by Application (2023-2028)
Table 153. Global GP Vaccination Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 154. Global GP Vaccination Revenue Market Share Forecast by Application (2023-2028)
Table 155. Global GP Vaccination Sales Forecast by Region (2023-2028) & (K Units)
Table 156. Global GP Vaccination Sales Market Share Forecast by Region (2023-2028)
Table 157. Global GP Vaccination Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 158. Global GP Vaccination Revenue Market Share Forecast by Region (2023-2028)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of GP Vaccination
Figure 2. Global GP Vaccination Market Share by Type in 2021 & 2028
Figure 3. DNA Product Picture
Figure 4. Non-replicating Viral Vector Product Picture
Figure 5. Protein Subunit Product Picture
Figure 6. RNA Product Picture
Figure 7. Others Product Picture
Figure 8. Global GP Vaccination Market Share by Application in 2021 & 2028
Figure 9. Adults
Figure 10. Children
Figure 11. Global GP Vaccination Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global GP Vaccination Market Size (2017-2028) & (US$ Million)
Figure 13. Global GP Vaccination Sales (2017-2028) & (K Units)
Figure 14. GP Vaccination Sales Share by Manufacturers in 2021
Figure 15. Global GP Vaccination Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest GP Vaccination Players: Market Share by Revenue in 2021
Figure 17. GP Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global GP Vaccination Sales Market Share by Region (2017-2022)
Figure 19. Global GP Vaccination Sales Market Share by Region in 2021
Figure 20. Global GP Vaccination Revenue Market Share by Region (2017-2022)
Figure 21. Global GP Vaccination Revenue Market Share by Region in 2021
Figure 22. United States GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE GP Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of GP Vaccination by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of GP Vaccination
Figure 46. Manufacturing Process Analysis of GP Vaccination
Figure 47. GP Vaccination Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed